Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ensoli

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Journal of Virology|April 10, 1999
Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cellsP Monini, F Carlini, M Stürzl, et al.
Vaccine|April 3, 2001
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)A Cafaro, F Titti, C Fracasso, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Blood|June 11, 1999
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcomaP Monini, S Colombini, M Stürzl, et al.
Scientific Reports|September 9, 2023
Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017-2019 multicenter cross-sectional studyMaria Teresa Maggiorella, L Sernicola, O Picconi, et al.
Reviews on Recent Clinical Trials|December 24, 2009
Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidateS Bellino, V Francavilla, O Longo, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
Journal of Virology|April 10, 1999
Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cellsP Monini, F Carlini, M Stürzl, et al.
Vaccine|April 3, 2001
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)A Cafaro, F Titti, C Fracasso, et al.
Journal of Medical Virology|August 16, 2001
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assaysO Schatz, P Monini, R Bugarini, et al.
Blood|June 11, 1999
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcomaP Monini, S Colombini, M Stürzl, et al.
Scientific Reports|September 9, 2023
Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017-2019 multicenter cross-sectional studyMaria Teresa Maggiorella, L Sernicola, O Picconi, et al.
Reviews on Recent Clinical Trials|December 24, 2009
Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidateS Bellino, V Francavilla, O Longo, et al.
Pageof 13